Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Blocking mTORC1 reduces skin tumor growth in mice.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Baricitinib is effective and safe for treating severe alopecia areata.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Erlotinib can cause hair loss as a side effect.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib can cause excessive hair growth.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Baricitinib is a promising treatment for alopecia areata.